干燥病相关气道疾病的特征分析
这项回顾性多中心研究纳入31例干燥病相关气道疾病(Sjo-AD)患者和62例无肺部受累的干燥病对照,发现Sjo-AD患者疾病活动度(ESSDAI)更高(7 vs 3.8,p<0.05),气道病变多为多肺叶(72%)并同时具有支气管扩张和细支气管炎征象(60%),随访期间肺功能稳定但41%患者CT显示病变扩展,无患者进展为干燥病相关间质性肺病。
要点
- Sjo-AD患者ESSDAI高于对照(7 vs 3.8,p<0.05),排除肺部域后仍更高。
- Sjo-AD多累及多肺叶(72%),常同时有支气管扩张和细支气管炎征象(60%)。
- 随访8.7±7年肺功能稳定,但6±3.2年内41%患者CT病变扩展,无进展为Sjo-ILD。
核心结论
- Sjo-AD主要见于生物学活动度较高的干燥病患者,常表现为同时累及近端和远端气道的弥漫性疾病,随时间缓慢演变且不进展为Sjo-ILD。
研究设计与样本
- 回顾性多中心研究,涉及9个中心,纳入31例经至少一名临床医生和一份CT报告确认的Sjo-AD患者及62例按年龄和病程匹配随机选取的无肺部受累干燥病对照。
- 收集临床和生物学数据、肺功能检查(PFT)及CT扫描,CT由一名胸部疾病专科放射科医生统一审阅。
主要发现
- Sjo-AD患者ESSDAI高于对照(7 vs 3.8,p<0.05),排除评分中肺部域后仍更高,主要归因于生物学活动。
- Sjo-AD呈多肺叶分布者占72%,同时具有支气管扩张和细支气管炎征象者占60%。
- 诊断Sjo-AD时32%存在阻塞性肺疾病。
- 随访8.7±7年后肺功能总体稳定,但6±3.2年内重复CT显示41%病例病变扩展。
- 无患者发生Sjo-ILD,Sjo-AD进展与整体疾病活动度无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Although airway disease associated with Sjögren's disease (Sjo-AD) is common, it is poorly studied compared with interstitial lung disease (ILD). In this study, we aimed to assess factors associated with Sjo-AD, the characteristics and prognosis of this manifestation. METHODS: We performed a retrospective multicentric study involving nine centres. We included Sjo-AD patients confirmed by at least one clinician and one CT scan report. Clinical and biological data, pulmonary function test (PFT), and CT scans were collected. A single radiologist specialist in thoracic diseases reviewed CT scans. Sjo-AD patients were compared with Sjo controls without pulmonary involvement, randomly selected after matching for age and disease duration. RESULTS: We included 31 Sjo-AD and 62 Sjo controls without pulmonary history. Sjo-AD had a higher disease activity (ESSDAI) compared with controls, even when excluding the pulmonary domain of the score (7 vs 3.8, p<0.05), mainly due to the biological activity. Sjo-AD was multilobar (72%) and associated with signs of both bronchiectasis and bronchiolitis (60%). Obstructive lung disease occurred in 32% at the time of Sjo-AD diagnosis. Overall, PFT was stable after 8.7±7 years follow-up but repeated CT scans showed extended lesions in 41% of cases within 6±3.2 years. No patient developed Sjo-ILD. Sjo-AD progression was independent of the global disease activity. CONCLUSIONS: Sjo-AD preferentially affects Sjo patients with higher biological activity. It is often characterised as a diffuse disease, affecting both proximal and distal airways, with a slow evolution over time and no progression to Sjo-ILD.
引用
- Meudec L, Debray MP, Beurnier A, et al. Characterisation of airway disease associated with Sjögren disease. RMD Open. 2024. PMID: 38428976. doi:10.1136/rmdopen-2023-003866
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。